Vivet Therapeutics SAS - Company Review
Vivet Therapeutics SAS - Company ReviewSummary
Vivet Therapeutics SAS (Vivet Therapeutics) is a gene therapy biotech company, which develops gene therapies for the treatment of inherited liver disorders. The company focuses on developing innovative gene therapy technologies and treatments for Wilson disease, progressive familiar intrahepatic cholestasis (PFIC), cirtullinemia and other indications. Vivet Therapeutics lead program VTX801, is a novel investigational gene therapy for Wilson disease. The company works in collaboration with Fundacion para la Investigacion Medica Aplicada (FIMA) and Massachusetts Eye and Ear (MEE) to develop gene therapy pipeline based on adeno associated virus (AAV) vectors, specifically aimed at the liver. Vivet Therapeutics is headquarterd in Paris, France.
This comprehensive company report of Vivet Therapeutics SAS provides you with company's businesses and operations information.
The profile contains critical company information including,
- Company Overview - A detailed description of the company's operations and business divisions.
- Major products and services - A list of major products, services and brands of the company.
- Key competitors - A list of key competitors to the company.
- Key employees - A list of the key executives of the company.
- Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
GlobalData is a one-stop solution for actionable insight into the pharmaceutical and medical device sectors. Together with the best team of researchers, analysts, epidemiologists and consultants, and an unmatched suite of proprietary databases, we provide high-quality, accurate and transparent insight that can help you achieve growth and increase business value.
Our valuable research and consulting solutions ensure you stay at the forefront of the industry by integrating accurate market forecasts and healthcare analytics on the latest trends and developments. Among other benefits, our informed healthcare industry perspectives have assisted businesses based across the pharmaceuticals, biotechnology and medical equipment markets in making strategic decisions that have increased the value of their products and services.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.